USDM Life Sciences

10/30/2026

Box named USDM its 2025 Life Sciences Partner of the Year. 🏆

Now we're bringing that experience to BoxWorks 2026.

You're already paying for Box AI. But can you use it on regulated content?

We helped a biopharma with ~1,000 contracts go from AI features no one could switch on to a validated AI hub Legal uses with confidence.

Bring the Box AI feature your team isn't using yet. We'll show you what it takes to turn it on.

📍 USDM booth · San Francisco Marriott Marquis · Nov 5–6
Book time with our team: https://www.usdm.com/resources/news-events/boxworks-2026-usdm?utm_source=linkedin&utm_medium=organic_social&utm_campaign=boxworks_2026&utm_content=booth_award_post

10/29/2026

Cyber incidents in life sciences aren’t just about stolen data anymore. They can stop orders, expose patient information, and pull in every vendor you rely on.

So the real question is whether your business can keep running when something goes wrong. Watch our 30-second take, then read the full analysis: https://www.usdm.com/resources/blogs/boston-scientific-cyber-incident-life-sciences-risk

10/29/2026

Your Quality team wants to use AI. Your validation team has to be able to defend it.

That's the tension we hear from life sciences teams every week. AI can triage deviations or route complaints in seconds, but if no one can prove its answers are reliable, it never makes it past the pilot.

The way forward is to start small and make it testable. Choose one high-volume decision with a fixed set of outcomes, test it against cases your SMEs have already reviewed, and send anything uncertain to a qualified person.

We help teams take that first step, from defining the decision to building the evidence an inspector will expect.

Which decision would your team want AI to handle first?https://www.usdm.com/resources/blogs/jev-ai-validation-gxp-decision-layer?utm_source=linkedin&utm_medium=organic_social&utm_campaign=ai_validation&utm_content=decision_layer_post

Blog post: Jev's bounded decision model shows how life sciences teams can validate AI decisions, apply CSA, and govern agentic GxP workflows with audit-ready evidence.

10/28/2026

Could you pass an AI audit today? FDA, EMA, and the EU AI Act all expect the same evidence. Are you ready?

Get the CxO Guide to Sustainable AI → https://www.usdm.com/resources/white-papers/cxo-guide-sustainable-ai

10/28/2026

A global biopharma company locked down its GxP systems with CyberArk.

There was just one problem: no one could prove it worked.

Auditors don’t accept “it’s installed.” They expect evidence that every control is implemented, tested, authorized and traceable.

USDM brought them into one qualification path:
🔹 Requirements finalized and approved before testing
🔹 Risk ratings and configuration matched to the real environment
🔹 Every deliverable routed through a controlled review
The result is an audit-ready control environment, plus a repeatable model for validating other cybersecurity systems.

Is your security team building controls with Quality, or handing them over at the end? 👇
Read the case study: https://www.usdm.com/resources/case-studies/qualifying-cybersecurity-controls-for-regulated-operations?utm_source=linkedin&utm_medium=organic_social&utm_campaign=cybersecurity&utm_content=case_study_cyberark

10/27/2026

Can AI actually survive an FDA inspection?

At the American Biomanufacturing Summit 2026, USDM's Hovsep Kirikian shared how one global CDMO used AI to cut deviation cycle time by 40%, and built it to hold up when the regulator walks through the door.

Watch the highlights ↓

Highlights from Hovsep Kirikian's full presentation at the 2026 Ame...

10/26/2026

Not every AI use case in GxP needs the same validation.
When a note-taking tool gets the same scrutiny as one that touches batch records, everything slows down.

The fix: sort AI use cases by risk first.
• How close is it to GxP records or decisions?
• How much does it act on its own?
• What happens if it's wrong?

Low-risk uses move fast. High-risk uses get the controls an inspector will expect.
Our CxO Guide to Sustainable AI shows life sciences leaders how to set this up.

Which AI use case is your team stuck validating?

Read the guide (form required): https://www.usdm.com/resources/white-papers/cxo-guide-sustainable-ai?utm_source=linkedin&utm_medium=organic_social&utm_campaign=cxo_sustainable_ai&utm_content=launch_post

10/23/2026

What is manual work costing your business?

Before you fund another AI pilot, know where it can make a difference. 47 use cases. Eight functions. One dossier.
Download it → https://www.usdm.com/resources/white-papers/ai-use-case-dossier

10/22/2026

Walk in with questions. Walk out with a plan for AI in your Box environment.

USDM is sponsoring BoxWorks 2026, and our team will be at the USDM booth in San Francisco on November 5–6.

AI agents can now work across your Box content. For life sciences teams, the harder part is using them in a way that holds up in an audit. Come talk to us about where to start, what to validate and how to keep it compliant.

📍 San Francisco Marriott Marquis | November 5–6

Want to plan ahead? Book time with our team 👇
https://www.usdm.com/resources/news-events/boxworks-2026-usdm

See you at BoxWorks!

10/22/2026

AI in life sciences isn't about whether it helps anymore. It's about where you put it to work. USDM + Glean make it real, on your data and inside your permissions.

Read more → https://www.usdm.com/resources/blogs/usdm-puts-ai-to-work-for-life-sciences